The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Effects of Brimonidine on Aqueous Humor Dynamics in Human Eyes
Abstract
OBJECTIVE: To evaluate the mechanism by which brimonidine, a selective alpha 2-adrenergic agonist, lowers intraocular pressure (IOP) in humans. SUBJECTS: Twenty-one volunteers with ocular hypertension. METHODS: Brimonidine tartrate (0.2%) was given topically twice daily for 1 week to one eye in a randomized, double-masked study. The fellow eye was similarly treated with brimonidine vehicle. Before (baseline) and after 1 week (day 8) of dosing, IOP, aqueous flow, episcleral venous pressure, and tonographic outflow facility were directly measured. Fluorophotometric outflow facility and uveoscleral outflow were calculated. Brimonidine-treated eyes were compared with vehicle-treated contralateral control eyes and with baseline measurements after 1 week of dosing. RESULTS: Brimonidine significantly (P < .001, Student's two-tailed t test) reduced IOP mean +/- SE of 4.7 +/- 0.7 and 4.2 +/- 0.4 mm Hg compared with the baseline day and with the vehicle-treated contralateral control eyes, respectively. Compared with the baseline day, aqueous flow was reduced by 20% (P = .002) and uveoscleral outflow was increased (P = .04). A slight contralateral decrease in IOP of 1.2 +/- 0.6 mm Hg (P = .05) and in aqueous flow of 12% (P = .05) was noted. No significant difference was seen in the outflow facility values or episcleral venous pressure compared with the baseline day or with the contralateral control eye. CONCLUSIONS: The brimonidine-induced reduction in IOP in humans is associated with a decrease in aqueous flow and an increase in uveoscleral outflow. The decrease in IOP and aqueous flow in the contralateral control eye on day 8 compared with the baseline day suggests a mild contralateral effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human Eyes
Toris, C. B., Camras, C. B., & Yablonski, M. E. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31484-3 · Cited by 413
Self-citationErnsberger, P., Giuliano, R., Willette, R. N., & Reis, D. J. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12477-4 · Cited by 332
UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypes
Cambridge, D. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90588-4 · Cited by 289
Keeping an eye on the I site: imidazoline-prefemng receptors
Martin C., M., & Paul, E. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90112-j · Cited by 175
Fluorophotometric Study of Epinephrine and Timolol in Human Subjects
Schenker, H. I., Yablonski, M. E., Podos, S. M., & Linder, L. (1981) · Archives of Ophthalmology · doi:10.1001/archopht.1981.03930020086007 · Cited by 145
Localization of Alpha-2 Adrenergic Receptors in the Human Eye
Matsuo, T., & Cynader, M. S. (2009) · Ophthalmic Research · doi:10.1159/000267170 · Cited by 55
Cited by
Krupin, T., Liebmann, J. M., Greenfield, D. S., Ritch, R., & Gardiner, S. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.09.026 · Cited by 394
Current management of glaucoma
Lusthaus, J., & Goldberg, I. (2019) · Medical Journal of Australia · doi:10.5694/mja2.50020 · Cited by 354
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma
Zhang, K., Zhang, L., & Weinreb, R. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3745 · Cited by 316
Metadata
- Authors
- Toris, C. B.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 1995-12-01
- Volume
- 113
- Issue
- 12
- Pages
- 1514
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2090110993
- Cited by
- 322
- References
- 6
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Brimonidine on Aqueous Humor Dynamics in Human Eyes. https://app.cochat.ai/papers/10.1001/archopht.1995.01100120044006
- The paper
- Toris, C. B. (1995). Effects of Brimonidine on Aqueous Humor Dynamics in Human Eyes. Archives of Ophthalmology. https://doi.org/10.1001/archopht.1995.01100120044006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.